Literature DB >> 28099215

Prevalence and Severity of Depression and Anxiety in Patients With Systemic Sclerosis: An Epidemiologic Survey and Investigation of Clinical Correlates.

Seyedeh Tahereh Faezi1, Pedram Paragomi, Ashraf Shahali, Maryam Akhlaghkhah, Mahmood Akbarian, Maassoomeh Akhlaghi, Masoumeh Kheirandish, Farhad Gharibdoost.   

Abstract

BACKGROUND: Systemic sclerosis (SSc) is a chronic multisystem connective tissue disorder with detrimental impact on quality of life. Patients with SSc face emotional distress and frequently meet criteria for a psychiatric disorder. However, the pattern of psychiatric manifestations may vary according to socioethnic background.
OBJECTIVES: We investigated the prevalence of depressive and anxiety symptoms and examined their association with sociodemographic and clinical factors in Iranian SSc patients.
METHODS: Depressive and anxiety symptoms were evaluated by Beck Depression Inventory and Cattell questionnaire in 114 SSc patients. The associations between sociodemographic and clinical factors and depressive/anxiety symptoms were examined via multivariate analysis.
RESULTS: The prevalence of depressive symptoms was 68.4%. There was a significant association between depressive symptoms and pulmonary and gastrointestinal manifestations. Also, diffuse SSc patients were more prone to depressive symptoms. Mean Rodnan scores were significantly higher in patients with depressive symptoms in comparison with subjects with no depressive symptoms. The prevalence of anxiety symptoms was 23.6%. Anxiety symptoms were not associated with demographic characteristics, SSc subtype, disease duration, Rodnan score, other clinical features, and previous history of depression in the patients or their family. The coincidence of anxiety and depression was 82.8%.
CONCLUSIONS: Depressive and anxiety symptoms are prevalent among Iranian SSc population. The depressive symptoms showed correlation with pulmonary and gastrointestinal involvement, as well as diffuse SSc subtype.

Entities:  

Mesh:

Year:  2017        PMID: 28099215     DOI: 10.1097/RHU.0000000000000428

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  4 in total

1.  Malnutrition, associated clinical factors, and depression in systemic sclerosis: a cross-sectional study.

Authors:  İpek Türk; Nihan Cüzdan; Volkan Çiftçi; Didem Arslan; Muharrem Cem Doğan; İlker Unal
Journal:  Clin Rheumatol       Date:  2019-05-26       Impact factor: 2.980

2.  Factors related to alexithymia in patients with systemic sclerosis: a tight relationship with facial image dissatisfaction.

Authors:  Fabio Basta; Domenico Paolo Emanuele Margiotta; Carmen Mazzuca; Veronica Batani; Giulio Dolcini; Patrizio Moras; Marta Vadacca; Antonella Afeltra
Journal:  Rheumatol Int       Date:  2018-11-29       Impact factor: 2.631

3.  Prevalence, Risk Factors and Assessment of Depressive Symptoms in Patients With Systemic Sclerosis.

Authors:  Christine March; Dörte Huscher; Emelina Preis; Alexander Makowka; Jakob Hoeppner; Frank Buttgereit; Gabriela Riemekasten; Kristina Norman; Elise Siegert
Journal:  Arch Rheumatol       Date:  2019-01-28       Impact factor: 1.472

4.  Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study.

Authors:  Eun Hye Park; Vibeke Strand; Yoon Jeong Oh; Yeong Wook Song; Eun Bong Lee
Journal:  Arthritis Res Ther       Date:  2019-02-15       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.